Gene expression tests for women with early stage breast cancer : a review of clinical utility and cost-effectiveness /
While each gene expression test has been independently clinically validated using prospective or retrospective evidence, currently, there is no gold-standard for breast cancer gene expression tests. This highlights the need for comparative assessments of clinical utility and cost-effectiveness.
Saved in:
| Online Access: |
http://www.ncbi.nlm.nih.gov/books/NBK513363/ Full text |
|---|---|
| Main Authors: | , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Ottawa (ON) :
Canadian Agency for Drugs and Technologies in Health,
2017
|
| Edition: | Version 1.0. |
| Series: | Rapid response report (Canadian Agency for Drugs and Technologies in Health)
|
| Subjects: |
